STOCK TITAN

[6-K] Cresco Labs Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Analyzing...
Positive
  • None.
Negative
  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of September, 2025
000-56241
(Commission File Number)
Cresco Labs Inc.
(Exact name of Registrant as specified in its charter)
600 W. Fulton Street, Suite 800
Chicago, IL 60661

(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☐    Form 40-F ☒



EXHIBIT INDEX
Exhibit No.Description
99.1
News Release dated September 16, 2025


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CRESCO LABS INC.
Date: September 17, 2025By:/s/ Charles Bachtell
Charles Bachtell
Chief Executive Officer


Cresco Labs

OTC:CRLBF

CRLBF Rankings

CRLBF Latest News

CRLBF Latest SEC Filings

CRLBF Stock Data

369.38M
332.59M
1.72%
7.71%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Chicago